Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0X3MK
|
|||
Former ID |
DIB019794
|
|||
Drug Name |
DZNep
|
|||
Synonyms |
3-deazaneplanocin A
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C12H14N4O3
|
|||
Canonical SMILES |
C1=CN=C(C2=C1N(C=N2)C3C=C(C(C3O)O)CO)N
|
|||
InChI |
1S/C12H14N4O3/c13-12-9-7(1-2-14-12)16(5-15-9)8-3-6(4-17)10(18)11(8)19/h1-3,5,8,10-11,17-19H,4H2,(H2,13,14)/t8-,10-,11+/m1/s1
|
|||
InChIKey |
OMKHWTRUYNAGFG-IEBDPFPHSA-N
|
|||
CAS Number |
CAS 102052-95-9
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
615106, 8195549, 15221583, 24717549, 43129111, 75061254, 92098549, 103064415, 103078364, 103405348, 104354458, 109693483, 117524162, 118047210, 126683146, 135030528, 137263204, 138769807, 152258216, 152344544, 160647052, 162768946, 184607915, 186014818, 204400609, 223653078, 227133899, 237369420, 249492591, 252214387, 252392863, 252428751, 252476359
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Adenosylhomocysteinase (AHCY) | Target Info | Inhibitor | [1] |
BioCyc | Superpathway of methionine degradation | |||
Methionine degradation | ||||
Cysteine biosynthesis | ||||
KEGG Pathway | Cysteine and methionine metabolism | |||
Metabolic pathways | ||||
Pathwhiz Pathway | Selenoamino Acid Metabolism | |||
Betaine Metabolism | ||||
Methionine Metabolism | ||||
WikiPathways | Metabolism of amino acids and derivatives | |||
Trans-sulfuration and one carbon metabolism | ||||
One Carbon Metabolism | ||||
Trans-sulfuration pathway | ||||
Phase II conjugation | ||||
Folate Metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | 3-Deazaneplanocin: a new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60. Biochem Biophys Res Commun. 1986 Mar 13;135(2):688-94. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.